Giannasi G, Ferrari S, Galetta F
Minerva Cardioangiol. 1995 May;43(5):169-75.
Fibrinogen is a globulin of hepatic synthesis necessary for the coagulative process and is considered a risk factor of atherosclerosis disease. The increase in plasma fibrinogen seems to play an important role in the atherosclerosis disease and actually it represents a major, independent risk factor that should be considered for screening programs aimed at identifying individuals at high risk for cardiovascular disease. In the present review we'll propose to summarize current pharmacological knowledge, the relationship between fibrinogen and the best known cardiovascular factors like smoking and hypercholesterolemia. Furthermore we'll show the main mechanisms which make hyperfibrinogenaemia a pathogenetic factor of atherosclerosis. Lastly we analyse the possible fibrinogen lowering therapy.
纤维蛋白原是肝脏合成的一种球蛋白,是凝血过程所必需的,被认为是动脉粥样硬化疾病的一个危险因素。血浆纤维蛋白原的升高似乎在动脉粥样硬化疾病中起重要作用,实际上它是一个主要的独立危险因素,在旨在识别心血管疾病高危个体的筛查项目中应予以考虑。在本综述中,我们将总结当前的药理学知识、纤维蛋白原与吸烟和高胆固醇血症等最知名心血管因素之间的关系。此外,我们将展示使高纤维蛋白原血症成为动脉粥样硬化发病因素的主要机制。最后,我们分析可能的降低纤维蛋白原的治疗方法。